symbol,statement_type,period_end,line_item,value
NUCLEUS.NS,cashflow,2025-03-31 00:00:00,Free Cash Flow,1357200000.0
NUCLEUS.NS,cashflow,2025-03-31 00:00:00,Repurchase Of Capital Stock,-892100000.0
NUCLEUS.NS,cashflow,2025-03-31 00:00:00,Capital Expenditure,-152200000.0
NUCLEUS.NS,cashflow,2025-03-31 00:00:00,End Cash Position,504600000.0
NUCLEUS.NS,cashflow,2025-03-31 00:00:00,Beginning Cash Position,458000000.0
NUCLEUS.NS,cashflow,2025-03-31 00:00:00,Effect Of Exchange Rate Changes,3000000.0
NUCLEUS.NS,cashflow,2025-03-31 00:00:00,Changes In Cash,43600000.0
NUCLEUS.NS,cashflow,2025-03-31 00:00:00,Financing Cash Flow,-1258000000.0
NUCLEUS.NS,cashflow,2025-03-31 00:00:00,Interest Paid Cff,-3200000.0
NUCLEUS.NS,cashflow,2025-03-31 00:00:00,Cash Dividends Paid,-334700000.0
NUCLEUS.NS,cashflow,2025-03-31 00:00:00,Common Stock Dividend Paid,-334700000.0
NUCLEUS.NS,cashflow,2025-03-31 00:00:00,Net Common Stock Issuance,-892100000.0
NUCLEUS.NS,cashflow,2025-03-31 00:00:00,Common Stock Payments,-892100000.0
NUCLEUS.NS,cashflow,2025-03-31 00:00:00,Investing Cash Flow,-207800000.0
NUCLEUS.NS,cashflow,2025-03-31 00:00:00,Interest Received Cfi,24800000.0
NUCLEUS.NS,cashflow,2025-03-31 00:00:00,Dividends Received Cfi,4400000.0
NUCLEUS.NS,cashflow,2025-03-31 00:00:00,Net Investment Purchase And Sale,-84800000.0
NUCLEUS.NS,cashflow,2025-03-31 00:00:00,Net PPE Purchase And Sale,-152200000.0
NUCLEUS.NS,cashflow,2025-03-31 00:00:00,Sale Of PPE,0.0
NUCLEUS.NS,cashflow,2025-03-31 00:00:00,Purchase Of PPE,-152200000.0
NUCLEUS.NS,cashflow,2025-03-31 00:00:00,Operating Cash Flow,1509400000.0
NUCLEUS.NS,cashflow,2025-03-31 00:00:00,Taxes Refund Paid,-393900000.0
NUCLEUS.NS,cashflow,2025-03-31 00:00:00,Change In Working Capital,178300000.0
NUCLEUS.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Assets,-1200000.0
NUCLEUS.NS,cashflow,2025-03-31 00:00:00,Change In Payable,-35600000.0
NUCLEUS.NS,cashflow,2025-03-31 00:00:00,Change In Receivables,337300000.0
NUCLEUS.NS,cashflow,2025-03-31 00:00:00,Other Non Cash Items,-250700000.0
NUCLEUS.NS,cashflow,2025-03-31 00:00:00,Provisionand Write Offof Assets,
NUCLEUS.NS,cashflow,2025-03-31 00:00:00,Deferred Tax,46700000.0
NUCLEUS.NS,cashflow,2025-03-31 00:00:00,Depreciation And Amortization,148100000.0
NUCLEUS.NS,cashflow,2025-03-31 00:00:00,Depreciation,148100000.0
NUCLEUS.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Investment Securities,-396600000.0
NUCLEUS.NS,cashflow,2025-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,3000000.0
NUCLEUS.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Sale Of PPE,0.0
NUCLEUS.NS,cashflow,2025-03-31 00:00:00,Net Income From Continuing Operations,2190500000.0
NUCLEUS.NS,cashflow,2024-03-31 00:00:00,Free Cash Flow,1933900000.0
NUCLEUS.NS,cashflow,2024-03-31 00:00:00,Repurchase Of Capital Stock,0.0
NUCLEUS.NS,cashflow,2024-03-31 00:00:00,Capital Expenditure,-286400000.0
NUCLEUS.NS,cashflow,2024-03-31 00:00:00,End Cash Position,458000000.0
NUCLEUS.NS,cashflow,2024-03-31 00:00:00,Beginning Cash Position,504900000.0
NUCLEUS.NS,cashflow,2024-03-31 00:00:00,Effect Of Exchange Rate Changes,4300000.0
NUCLEUS.NS,cashflow,2024-03-31 00:00:00,Changes In Cash,-51200000.0
NUCLEUS.NS,cashflow,2024-03-31 00:00:00,Financing Cash Flow,-301600000.0
NUCLEUS.NS,cashflow,2024-03-31 00:00:00,Interest Paid Cff,-5400000.0
NUCLEUS.NS,cashflow,2024-03-31 00:00:00,Cash Dividends Paid,-267700000.0
NUCLEUS.NS,cashflow,2024-03-31 00:00:00,Common Stock Dividend Paid,-267700000.0
NUCLEUS.NS,cashflow,2024-03-31 00:00:00,Net Common Stock Issuance,0.0
NUCLEUS.NS,cashflow,2024-03-31 00:00:00,Common Stock Payments,0.0
NUCLEUS.NS,cashflow,2024-03-31 00:00:00,Investing Cash Flow,-1969900000.0
NUCLEUS.NS,cashflow,2024-03-31 00:00:00,Interest Received Cfi,-34400000.0
NUCLEUS.NS,cashflow,2024-03-31 00:00:00,Dividends Received Cfi,4400000.0
NUCLEUS.NS,cashflow,2024-03-31 00:00:00,Net Investment Purchase And Sale,-1660700000.0
NUCLEUS.NS,cashflow,2024-03-31 00:00:00,Net PPE Purchase And Sale,-279200000.0
NUCLEUS.NS,cashflow,2024-03-31 00:00:00,Sale Of PPE,7200000.0
NUCLEUS.NS,cashflow,2024-03-31 00:00:00,Purchase Of PPE,-286400000.0
NUCLEUS.NS,cashflow,2024-03-31 00:00:00,Operating Cash Flow,2220300000.0
NUCLEUS.NS,cashflow,2024-03-31 00:00:00,Taxes Refund Paid,-774700000.0
NUCLEUS.NS,cashflow,2024-03-31 00:00:00,Change In Working Capital,710600000.0
NUCLEUS.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Assets,-116300000.0
NUCLEUS.NS,cashflow,2024-03-31 00:00:00,Change In Payable,41900000.0
NUCLEUS.NS,cashflow,2024-03-31 00:00:00,Change In Receivables,63400000.0
NUCLEUS.NS,cashflow,2024-03-31 00:00:00,Other Non Cash Items,-149700000.0
NUCLEUS.NS,cashflow,2024-03-31 00:00:00,Provisionand Write Offof Assets,
NUCLEUS.NS,cashflow,2024-03-31 00:00:00,Deferred Tax,56200000.0
NUCLEUS.NS,cashflow,2024-03-31 00:00:00,Depreciation And Amortization,145500000.0
NUCLEUS.NS,cashflow,2024-03-31 00:00:00,Depreciation,145500000.0
NUCLEUS.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Investment Securities,-328500000.0
NUCLEUS.NS,cashflow,2024-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-2900000.0
NUCLEUS.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Sale Of PPE,-6700000.0
NUCLEUS.NS,cashflow,2024-03-31 00:00:00,Net Income From Continuing Operations,2558000000.0
NUCLEUS.NS,cashflow,2023-03-31 00:00:00,Free Cash Flow,461400000.0
NUCLEUS.NS,cashflow,2023-03-31 00:00:00,Repurchase Of Capital Stock,0.0
NUCLEUS.NS,cashflow,2023-03-31 00:00:00,Capital Expenditure,-37000000.0
NUCLEUS.NS,cashflow,2023-03-31 00:00:00,End Cash Position,504900000.0
NUCLEUS.NS,cashflow,2023-03-31 00:00:00,Beginning Cash Position,357500000.0
NUCLEUS.NS,cashflow,2023-03-31 00:00:00,Effect Of Exchange Rate Changes,2500000.0
NUCLEUS.NS,cashflow,2023-03-31 00:00:00,Changes In Cash,144900000.0
NUCLEUS.NS,cashflow,2023-03-31 00:00:00,Financing Cash Flow,-226500000.0
NUCLEUS.NS,cashflow,2023-03-31 00:00:00,Interest Paid Cff,-5900000.0
NUCLEUS.NS,cashflow,2023-03-31 00:00:00,Cash Dividends Paid,-187400000.0
NUCLEUS.NS,cashflow,2023-03-31 00:00:00,Common Stock Dividend Paid,-187400000.0
NUCLEUS.NS,cashflow,2023-03-31 00:00:00,Net Common Stock Issuance,0.0
NUCLEUS.NS,cashflow,2023-03-31 00:00:00,Common Stock Payments,0.0
NUCLEUS.NS,cashflow,2023-03-31 00:00:00,Investing Cash Flow,-127000000.0
NUCLEUS.NS,cashflow,2023-03-31 00:00:00,Interest Received Cfi,80600000.0
NUCLEUS.NS,cashflow,2023-03-31 00:00:00,Dividends Received Cfi,5000000.0
NUCLEUS.NS,cashflow,2023-03-31 00:00:00,Net Investment Purchase And Sale,-179500000.0
NUCLEUS.NS,cashflow,2023-03-31 00:00:00,Net PPE Purchase And Sale,-33100000.0
NUCLEUS.NS,cashflow,2023-03-31 00:00:00,Sale Of PPE,3900000.0
NUCLEUS.NS,cashflow,2023-03-31 00:00:00,Purchase Of PPE,-37000000.0
NUCLEUS.NS,cashflow,2023-03-31 00:00:00,Operating Cash Flow,498400000.0
NUCLEUS.NS,cashflow,2023-03-31 00:00:00,Taxes Refund Paid,-273500000.0
NUCLEUS.NS,cashflow,2023-03-31 00:00:00,Change In Working Capital,-874000000.0
NUCLEUS.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Assets,-23500000.0
NUCLEUS.NS,cashflow,2023-03-31 00:00:00,Change In Payable,-19900000.0
NUCLEUS.NS,cashflow,2023-03-31 00:00:00,Change In Receivables,-915500000.0
NUCLEUS.NS,cashflow,2023-03-31 00:00:00,Other Non Cash Items,-63300000.0
NUCLEUS.NS,cashflow,2023-03-31 00:00:00,Provisionand Write Offof Assets,
NUCLEUS.NS,cashflow,2023-03-31 00:00:00,Deferred Tax,29800000.0
NUCLEUS.NS,cashflow,2023-03-31 00:00:00,Depreciation And Amortization,187300000.0
NUCLEUS.NS,cashflow,2023-03-31 00:00:00,Depreciation,187300000.0
NUCLEUS.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Investment Securities,-214100000.0
NUCLEUS.NS,cashflow,2023-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-5600000.0
NUCLEUS.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Sale Of PPE,-3600000.0
NUCLEUS.NS,cashflow,2023-03-31 00:00:00,Net Income From Continuing Operations,1710800000.0
NUCLEUS.NS,cashflow,2022-03-31 00:00:00,Free Cash Flow,334300000.0
NUCLEUS.NS,cashflow,2022-03-31 00:00:00,Repurchase Of Capital Stock,-1911200000.0
NUCLEUS.NS,cashflow,2022-03-31 00:00:00,Capital Expenditure,-242400000.0
NUCLEUS.NS,cashflow,2022-03-31 00:00:00,End Cash Position,357500000.0
NUCLEUS.NS,cashflow,2022-03-31 00:00:00,Beginning Cash Position,322700000.0
NUCLEUS.NS,cashflow,2022-03-31 00:00:00,Effect Of Exchange Rate Changes,1500000.0
NUCLEUS.NS,cashflow,2022-03-31 00:00:00,Changes In Cash,33300000.0
NUCLEUS.NS,cashflow,2022-03-31 00:00:00,Financing Cash Flow,-2128800000.0
NUCLEUS.NS,cashflow,2022-03-31 00:00:00,Interest Paid Cff,-4200000.0
NUCLEUS.NS,cashflow,2022-03-31 00:00:00,Cash Dividends Paid,-174200000.0
NUCLEUS.NS,cashflow,2022-03-31 00:00:00,Common Stock Dividend Paid,-174200000.0
NUCLEUS.NS,cashflow,2022-03-31 00:00:00,Net Common Stock Issuance,-1911200000.0
NUCLEUS.NS,cashflow,2022-03-31 00:00:00,Common Stock Payments,-1911200000.0
NUCLEUS.NS,cashflow,2022-03-31 00:00:00,Investing Cash Flow,1585400000.0
NUCLEUS.NS,cashflow,2022-03-31 00:00:00,Interest Received Cfi,167100000.0
NUCLEUS.NS,cashflow,2022-03-31 00:00:00,Dividends Received Cfi,10000000.0
NUCLEUS.NS,cashflow,2022-03-31 00:00:00,Net Investment Purchase And Sale,1648300000.0
NUCLEUS.NS,cashflow,2022-03-31 00:00:00,Net PPE Purchase And Sale,-240000000.0
NUCLEUS.NS,cashflow,2022-03-31 00:00:00,Sale Of PPE,2400000.0
NUCLEUS.NS,cashflow,2022-03-31 00:00:00,Purchase Of PPE,-242400000.0
NUCLEUS.NS,cashflow,2022-03-31 00:00:00,Operating Cash Flow,576700000.0
NUCLEUS.NS,cashflow,2022-03-31 00:00:00,Taxes Refund Paid,-161900000.0
NUCLEUS.NS,cashflow,2022-03-31 00:00:00,Change In Working Capital,301200000.0
NUCLEUS.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Assets,-59500000.0
NUCLEUS.NS,cashflow,2022-03-31 00:00:00,Change In Payable,12200000.0
NUCLEUS.NS,cashflow,2022-03-31 00:00:00,Change In Receivables,69600000.0
NUCLEUS.NS,cashflow,2022-03-31 00:00:00,Other Non Cash Items,-87100000.0
NUCLEUS.NS,cashflow,2022-03-31 00:00:00,Provisionand Write Offof Assets,
NUCLEUS.NS,cashflow,2022-03-31 00:00:00,Deferred Tax,31200000.0
NUCLEUS.NS,cashflow,2022-03-31 00:00:00,Depreciation And Amortization,153800000.0
NUCLEUS.NS,cashflow,2022-03-31 00:00:00,Depreciation,153800000.0
NUCLEUS.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Investment Securities,-211800000.0
NUCLEUS.NS,cashflow,2022-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-10700000.0
NUCLEUS.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Sale Of PPE,-1200000.0
NUCLEUS.NS,cashflow,2022-03-31 00:00:00,Net Income From Continuing Operations,555000000.0
NUCLEUS.NS,cashflow,2021-03-31 00:00:00,Free Cash Flow,
NUCLEUS.NS,cashflow,2021-03-31 00:00:00,Repurchase Of Capital Stock,
NUCLEUS.NS,cashflow,2021-03-31 00:00:00,Capital Expenditure,
NUCLEUS.NS,cashflow,2021-03-31 00:00:00,End Cash Position,
NUCLEUS.NS,cashflow,2021-03-31 00:00:00,Beginning Cash Position,
NUCLEUS.NS,cashflow,2021-03-31 00:00:00,Effect Of Exchange Rate Changes,
NUCLEUS.NS,cashflow,2021-03-31 00:00:00,Changes In Cash,
NUCLEUS.NS,cashflow,2021-03-31 00:00:00,Financing Cash Flow,
NUCLEUS.NS,cashflow,2021-03-31 00:00:00,Interest Paid Cff,
NUCLEUS.NS,cashflow,2021-03-31 00:00:00,Cash Dividends Paid,
NUCLEUS.NS,cashflow,2021-03-31 00:00:00,Common Stock Dividend Paid,
NUCLEUS.NS,cashflow,2021-03-31 00:00:00,Net Common Stock Issuance,
NUCLEUS.NS,cashflow,2021-03-31 00:00:00,Common Stock Payments,
NUCLEUS.NS,cashflow,2021-03-31 00:00:00,Investing Cash Flow,
NUCLEUS.NS,cashflow,2021-03-31 00:00:00,Interest Received Cfi,
NUCLEUS.NS,cashflow,2021-03-31 00:00:00,Dividends Received Cfi,
NUCLEUS.NS,cashflow,2021-03-31 00:00:00,Net Investment Purchase And Sale,
NUCLEUS.NS,cashflow,2021-03-31 00:00:00,Net PPE Purchase And Sale,
NUCLEUS.NS,cashflow,2021-03-31 00:00:00,Sale Of PPE,
NUCLEUS.NS,cashflow,2021-03-31 00:00:00,Purchase Of PPE,
NUCLEUS.NS,cashflow,2021-03-31 00:00:00,Operating Cash Flow,
NUCLEUS.NS,cashflow,2021-03-31 00:00:00,Taxes Refund Paid,
NUCLEUS.NS,cashflow,2021-03-31 00:00:00,Change In Working Capital,
NUCLEUS.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Assets,
NUCLEUS.NS,cashflow,2021-03-31 00:00:00,Change In Payable,
NUCLEUS.NS,cashflow,2021-03-31 00:00:00,Change In Receivables,
NUCLEUS.NS,cashflow,2021-03-31 00:00:00,Other Non Cash Items,
NUCLEUS.NS,cashflow,2021-03-31 00:00:00,Provisionand Write Offof Assets,0.0
NUCLEUS.NS,cashflow,2021-03-31 00:00:00,Deferred Tax,
NUCLEUS.NS,cashflow,2021-03-31 00:00:00,Depreciation And Amortization,
NUCLEUS.NS,cashflow,2021-03-31 00:00:00,Depreciation,
NUCLEUS.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Investment Securities,
NUCLEUS.NS,cashflow,2021-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,
NUCLEUS.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Sale Of PPE,
NUCLEUS.NS,cashflow,2021-03-31 00:00:00,Net Income From Continuing Operations,
